MADRIGAL PHARMACEUTICALS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$80M
Free Cash Flow↑+10240.3% +$80M
$79M
Investing Cash Flow
$28M
Financing Cash Flow↓-54.7% -$11M
$9M
Capex↑+10.0% +$78K
$857K
Stock-Based Comp↑+45.9% +$8M
$26M
D&A↑+8.0% +$29K
$392K
SBC Allocated Expense↑+45.9% +$8M
$26M
SBC Unrecognized Cost
$5M